Introduction {#s1}
============

Sleep duration has become increasingly acknowledged as an important factor in overall health status, and sleep deficiency has begun to be recognized as a potential modifiable risk factor for certain chronic conditions. Current research has shown that short sleep duration (SSD), defined as \<7 h/night, is associated with an increased risk of obesity, metabolic disorders, and CVD ([@B1]--[@B4]). This association may be U-shaped, however, as there is also evidence that longer sleep duration, \>9 h/night, is associated with adverse health effects ([@B5]). However, in today\'s "24/7\" society, short sleep duration is more prevalent that long sleep duration. According to data from the National Health Interview Survey, the prevalence of very short sleep (\<5 h) and short sleep (5--6 h) has increased from 1.7 to 2.4% and 19.7 to 26.7%, respectively, from 1977 to 2009 ([@B6]). Concurrently, long sleep (\>9 h) decreased from 11.6 to 7.8% ([@B6]). This rise in the prevalence of short sleepers has permitted epidemiological evaluations of the influence of sleep duration on cardiometabolic risk factors. The data from these studies suggest a relation between sleep duration and obesity, hypertension, type 2 diabetes, and overall mortality ([@B7], [@B8]). These results have led to intervention studies to further examine the causal implications of these findings.

There are several mechanisms by which SSD may be related to obesity: metabolic changes affecting appetite-regulating hormones ([@B9]); low physical activity; and increased food intake without comparable change in energy expenditure ([@B10], [@B11]). Leptin is an adipocyte derived hormone that plays in important role in energy homeostasis ([@B12]). Its effect on energy balance regulation and SSD has been extensively studied, but with mixed results ([@B13]--[@B15]). Multiple clinical studies have shown that sleep restriction, in healthy, normal sleepers (7--9 h), leads to increases in daily energy intake ([@B16]--[@B18]) sufficient to lead to weight gain if sustained over time ([@B18]). On the other hand, there are conflicting reports regarding the impact of sleep restriction on energy expenditure ([@B11], [@B17], [@B18]). Nonetheless, it seems that any change in energy expenditure due to sleep restriction is either insufficient to offset the increase in energy intake or contributes to the positive energy balance.

Increased blood pressure (BP) and inflammatory markers, such as interleukin-6 (IL-6), are associated with systemic inflammation and decreased cardiovascular health ([@B19]). There are several clinical intervention studies examining the impact of sleep restriction, for periods ranging from a few days to a few weeks, on cardiometabolic risk factors ([@B2]--[@B4], [@B20]). When examining metabolic health, studies have demonstrated that sleep restriction reduces whole body insulin sensitivity and insulin resistance at a cellular level ([@B21], [@B22]). However, evidence linking SSD to adverse cardiometabolic risk does not de facto imply a benefit of sleep extension on health outcomes. In this review, we describe the cardiometabolic effects of sleep restriction, and we highlight and critically evaluate current interventions that aim to extend the duration of sleep in short-sleepers as a means of improving cardiometabolic risk factors. These studies are summarized in Table [1](#T1){ref-type="table"}. We also address opportunities for future research in this area.

###### 

Summary of clinical studies included in the present review that investigated the health effects of sleep extension.

  **Study Ref**               **Intervention**                                                                                                           **Participants**                                        **Duration (Weeks)**   **Methods**                                                                                                        **Sleep as an outcome**                                                          **Intervention group results**
  --------------------------- -------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------- ---------------------- ------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------
  Logue et al. ([@B23])       Weekly group counseling sessions                                                                                           25 overweight and obese adults                          12                     Group 1: diet and exercise counseling Group 2: diet and exercise counseling plus sleep education starting week 4   No Primary outcome: weight loss                                                  Group 2 lost more weight compared to Group 1 (change of −5 vs. −2%) No difference in sleep quality
  Tasali et al. ([@B24])      1 individual counseling session at baseline to extend sleep and prescribe a sleep schedule                                 10 overweight adults                                    2                      All subjects: increase TIB to 8.5 h/night, monitored with actigraphy No comparison group                           Yes Extending sleep will improve appetite and decrease cravings                  14% decrease in overall appetite and a 62% decrease in the desire for sweet and salty foods
  Al Khatib et al. ([@B25])   1 individual counseling session at baseline to extend sleep and prescribe a sleep schedule                                 41 healthy, normal weight adults                        4                      Sleep extension group: extend sleep by 1--1.5 h/night, monitored with actigraphy Control group                     Yes Extending sleep will improve weight maintenance and cardiometabolic health   Reduced intake of free sugars (−9.6 g) compared baseline
  Haack et al. ([@B26])       Both groups received sleep hygiene information at baseline Extension group was prescribed individualized sleep schedules   22 adults with prehypertension or type 1 hypertension   6                      Sleep extension group: extend sleep by 1 h/night, monitored with actigraphy Control group                          Yes Extending sleep lowers BP                                                    Decreased average systolic and diastolic beat-to-beat BP from baseline to endpoint (14 ± 3 vs. 8 ± 3 mmHg)
  McGrath et al. ([@B27])     Weekly individual sleep counseling                                                                                         134 adults with elevated BP                             8                      Sleep intervention group: 60 min counseling session using Sleepio Standard care group                              No Primary outcome: reduce mean 24 h BP                                          Reported improved sleep quality, no changes in BP
  Leproult et al. ([@B28])    1 individual counseling session at baseline to extend sleep and prescribe a sleep schedule                                 16 healthy adults                                       6                      All subjects: extend sleep by 1 h/night, verified by actigraphy No comparison group                                Yes Extending sleep will improve metabolic health                                Improved insulin-to-glucose ratios

Endocrine and cardiometabolic effects of recovery sleep after sleep restriction {#s2}
===============================================================================

In today\'s society, it is common for individuals to decrease their sleep during the work week, and to attempt to "catch-up" by sleeping longer on the weekends. It is reported that about 56% of Americans sleep less during the work week compared to non-work days ([@B29]). Several clinical trials have reproduced this scenario to understand the health effects of short term sleep recovery. Van Leeuwen et al. ([@B30]) tested the effects of sleep restriction and subsequent recovery sleep on glucose, leptin, and satiety in healthy men. Participants were sleep restricted for 5 days with a time in bed (TIB) of 4 h/night followed by a 2-day sleep recovery of 8 h TIB. Leptin levels were elevated during sleep restriction and remained elevated during the recovery period, compared to baseline, but no differences were found in subjective satiety measures throughout the experiment in both groups. It is possible that leptin remained elevated because an 8 h TIB was not an adequate amount of time to allow sufficient recovery sleep after 5 nights of \<4 h sleep ([@B31]). Faraut et al. ([@B31]) investigated the effects that napping and recovery sleep had on the immune and inflammatory systems of healthy young men. Participants were restricted to 2 h TIB for one night followed by either an 8 h recovery night, a 30-min nap mid-day plus an 8 h recovery night, or a 10 h recovery night. The control group slept 3 consecutive nights of 8 h, with no changes in immune or inflammatory parameters throughout the experiment. Leukocyte counts increased in all sleep restricted groups compared to baseline, but this increase persisted in the 8 h recovery condition, while the numbers decreased in the nap + 8 h recovery and the 10 h recovery conditions. There was only a significant increase in myeloperoxidases in the sleep restriction +8 h recovery group; this increase was significant during both the restriction and recovery periods compared to baseline. The control and other 2 sleep restriction groups experienced no changes in inflammatory markers.

Spiegel et al. ([@B32]) used a more appropriate recovery sleep episode of 12 h TIB for 7 nights after participants were sleep restricted for 6 nights to 4 h TIB. In this group of healthy men, leptin levels during sleep restriction were 19% lower compared to the sleep recovery phase, suggesting that increasing sleep, following a period of drastically restricted sleep, may reverse the potential negative effects of short sleep on leptin levels. However, baseline leptin levels were not measured, and it is therefore unclear whether recovery sleep returned leptin levels to their baseline state or increased leptin levels. Difference between these two studies may have been due to the different lengths of the study or the duration of the recovery sleep period. The study by Spiegel et al. ([@B32]) had longer restriction and recovery phases than that of Van Leeuwen et al. ([@B30]), possibly allowing leptin to adapt to these changes in sleep. Another study ([@B13]) incrementally restricted sleep in 14 women for 4 nights, resulting in a decrease in leptin levels, with accompanying increases in energy intake and body weight. After 2 nights of recovery sleep, averaging 9.35 h/night, all of these parameters had returned to baseline.

In addition to energy balance outcomes, studies have also examined cardiometabolic risk factors in response to sleep extension. Van Leeuwen et al. ([@B30]) observed increases in fasting insulin and insulin-to-glucose ratio after sleep restriction, with both returning to baseline after the 2-night recovery period. Pejovic et al. ([@B33]) observed increases in 24 h plasma IL-6 levels following 6 nights of 6 h TIB. These levels returned to baseline after 3 nights of 10 h recovery sleep.

All of the interventions noted herein had limited short sleep restriction and sleep recovery periods, with no more than 7 days of recovery sleep. Despite the mixed results, these preliminary findings are encouraging and provide a basis for the potential reversibility of adverse health effects caused by sleep restriction through sleep extension. These studies have provided justification for examining sleep extension sleep, in short sleepers, as a means to provide endocrine and cardiometabolic health benefits. These investigations were undertaken to determine whether benefits would also be observed among chronic short sleepers, rather than sleep-restricted adequate sleepers, as included in the studies described above.

Impact of sleep extension on body weight {#s3}
========================================

Short-term recovery sleep studies suggest that the increase in weight and energy intake associated with sleep restriction may be ameliorated by extending sleep. Recent studies further tested this hypothesis but employed longer interventions in an outpatient setting. Logue et al. ([@B23]) performed a 12-week randomized controlled trial in overweight and obese adults, examining the effectiveness of lifestyle interventions on weight loss and sleep. The participants were randomized into 2 groups, each receiving weekly 60-min counseling sessions. Both groups received diet and exercise counseling, but the second group received additional sleep-related information starting at the week 4 session. Body weight was measured at each session and sleep quality and efficiency were assessed using the Pittsburgh Sleep Quality Index and the Sleep Timing Questionnaire, respectively, at weeks 0, 6, and 12. Food frequency questionnaires were collected at weeks 0 and 12. The results showed that both groups lost weight, but the group receiving additional sleep counseling lost more weight compared to the group only receiving diet and exercise counseling (−5% change from baseline vs. −2% change from baseline, respectively). In addition, both groups reported improved sleep efficiency, but no data regarding sleep duration were reported. These findings provide some evidence that following sleep recommendations, in addition to diet and exercise, may lead to greater weight loss than diet and exercise alone. However, given that both groups perceived improvements in sleep efficiency, it is unclear whether the sleep recommendations were instrumental in effecting greater weight loss. Indeed, there were several potential concerns with this study that should be noted: (1) the group receiving the additional sleep counseling ate significantly fewer added fats and sweets at baseline compared to the control group; when controlling for this, statistical significance disappeared; (2) retention rate was low, with approximately 54% of participants completing the study; (3) sleep was not assessed objectively and change in sleep duration as a result of the intervention could not be ascertained. These limitations decrease the impact of the study.

Another study ([@B24]) investigated the effects of behavioral counseling in combination with 2 weeks of sleep extension. Ten overweight adults, reporting sleeping \<6.5 h/night at baseline, were provided a single baseline behavioral counseling session on sleep hygiene and asked to lengthen their TIB to 8.5 h/night. An additional counseling session was provided after the first week of the intervention if the study team deemed it necessary. Prescribed bedtimes and wake times were given to individuals based on their preferred schedules. Wrist actigraphy was used to objectively measure sleep throughout the study, and appetite was assessed at baseline and endpoint using visual analog scales. At the end of the 2-week intervention, participants had increased their sleep duration by an average of 1.6 h compared to baseline (7.1 vs. 5.6 h). Additionally, there was a 14% decrease in overall appetite and a 62% decrease in the desire for sweet and salty foods. These results are encouraging given that a recent meta-analysis concluded that the increase in energy intake after sleep restriction is approximately 385 kcal/d, ([@B18]) which is sufficient to lead to weight gain if sustained over time. Furthermore, the increased consumption was accompanied by a significant increase in fat intake. Although the study lacked a control group, ([@B24]) the increase in sleep duration associated with the decrease in appetite is promising and should be followed by controlled trials to determine if increasing sleep duration from short to adequate reduces food intake, improves dietary habits, and leads to improved body weight over time. It is also important to note that the study did not assess actual food intake and was only 2 weeks long, a period too short to observe effects on body weight. Therefore, unanswered questions remain as to the influence of sleep extension on body weight.

There have been several mechanisms put forth to explain the increase in energy intakes observed with sleep restriction. One proposition is that sleep restriction leads to changes in appetite-regulating hormones. Similar to the recovery sleep studies, the effects sleep restriction has on these hormones, particularly leptin, are varied ([@B13]--[@B15]). Another is that sleep restriction stimulates neuronal networks associated with reward, which increases the salience of foods ([@B34]). Despite divergent opinions on the mechanism, there is strong consensus that sleep restriction leads to increased food intake ([@B17], [@B18], [@B35]). Thus, extending sleep could potentially reverse this increase in food intake. In a study performed by Al Khatib et al. ([@B25]) participants reported a reduced intake of free sugars compared to a control group after 4 weeks of 1--1.5 h/night sleep extension. This trial investigated the feasibility of sleep extension, via behavioral counseling, to affect body weight and cardiometabolic health. Forty-one healthy adults with body mass index 18.4--24.9 kg/m^2^ who were self-reported short sleepers (5--7 h/night) were enrolled. The goal for the sleep extension group was to lengthen sleep duration by 1--1.5 h/night for 4 weeks. This was attempted by providing a single sleep consultation at baseline to design and implement a personalized strategy with prescribed bed times and wake times. There were 4 in-person visits throughout the study, 2 at baseline and 2 at endpoint, to assess outcomes related to energy balance (food intake, energy expenditure, and body composition) and cardiometabolic risk factors (blood biomarkers and BP). Wrist actigraphy was used as an objective measure of sleep duration to verify participants\' adherence to sleep recommendations. At the end of the intervention, the sleep extension group had significantly increased their sleep duration by 21 min, whereas the control group reduced their sleep by 11 min. However, only 3 of 21 participants in the sleep extension group were able to reach the weekly sleep goal of 7--9 h of sleep/night. Possibly due to the minimal improvements in sleep duration in the sleep extension group, there was no significant difference in body composition or cardiometabolic risk factors between groups after the 4-week period. Additionally, relative to baseline, the sleep extension group experienced poorer sleep quality, as measured by actigraphy, compared to the control group. However, the sleep extension group reported improved perceived sleep quality compared to the control group, as reflected by a decrease in Pittsburgh Sleep Quality Index score. The decrease in sleep quality when measured objectively may have been the result of a longer TIB and may diminish over time.

Overall, these studies examining the impact of sleep extension on body weight regulation suggest that interventions including sleep education plus a prescribed sleep extension schedule have the potential to lead to improved body weight and food choices. However, several limitations hinder definitive statements and recommendations to lengthen sleep duration for weight management at this time. All of these studies are limited by their small sample size, with the intervention groups ranging from 10 to 21 subjects, and variability in participant characteristics. Additionally, while each provided some type of sleep education and counseling, the content was unique to each study and the extent of counseling (duration and intensity) varied between studies.

Impact of sleep extension on inflammation and blood pressure {#s4}
============================================================

Clinical interventions have provided evidence that restricting sleep is associated with increased inflammatory markers ([@B2]) and BP ([@B20]) which are associated with cardiovascular disease (CVD). Recently, several clinical trials have examined if sleep extension could help alleviate these risks. Haack et al. ([@B26]) performed a 6-week randomized controlled trial studying 22 adults with prehypertension or type 1 hypertension who slept 7 h/night or less. After 2 weeks of actigraphy recordings to verify short sleep, participants were randomized to a sleep extension group, where they were instructed to increase their TIB by 1 h and were prescribed individualized bed times and wake times, or to a sleep maintenance group, who kept their habitual bedtimes and wake times. Both groups received instructions on how to improve sleep hygiene and, at baseline and endpoint, 24 h BP was monitored and a fasting blood sample was taken. As hypothesized, at the end of the 6-week intervention period, the sleep extension group had an increase in daily sleep duration of 35 ± 9 min. Additionally, the systolic and diastolic beat-to-beat BP average over the 24 h recording significantly decreased in the sleep extension group from baseline to endpoint by 14 ± 3 and 8 ± 3 mmHg, respectively. Decreased beat-to-beat BP variability is associated with CVD, end organ damage, and vascular elasticity ([@B36], [@B37]). However, there were no changes in overall BP or inflammatory markers.

McGrath et al. ([@B27]) also examined adults with elevated BP who had self-reported difficulties sleeping. Within an 8-week trial, 134 participants who were self-reported poor sleepers were randomized to either standard care or sleep intervention. The intervention group received weekly lifestyle sessions using a tool called Sleepio. Sleepio is an online platform that provides education on sleep hygiene and cognitive behavioral therapy and has been shown to improve sleep quality in patients with insomnia ([@B38]). The study investigated whether there was a difference in 24 h systolic BP, 24 h diastolic BP, peak and mean diurnal and nocturnal systolic BP and diastolic BP, and sleep quality between the two groups. At the end of the 8 weeks, the intervention group reported improved sleep quality, but there was no difference between the intervention and standard care groups in BP or other CVD-related measures. Participants did not provide data on sleep duration at baseline. Additionally, no objective measure of sleep was obtained throughout the study, nor was there a sleep extension component. For these reasons, the trial may not have produced the same improvements observed previously, ([@B26]) despite its longer intervention period and larger sample size. Although the study by McGrath et al. ([@B27]) showed no significant results regarding BP, the improved beat-to-beat BP average observed by Haack et al. ([@B26]) is encouraging and warrants further investigation into the role sleep extension may have in modulating CVD risk.

Impact of sleep extension on glucose and insulin sensitivity {#s5}
============================================================

Insulin resistance is associated with numerous diseases including obesity, metabolic syndrome, and type 2 diabetes mellitus ([@B39]). Sleep may be a potential modifiable risk factor for these disorders ([@B1]). There is extensive research describing the negative effects sleep restriction on glucose levels and insulin sensitivity, ([@B21], [@B22], [@B40]) however there is much less information available on the effects of sleep extension on these outcomes. In fact, we could find only one study that investigated the effects of sleep extension on glucose and insulin ([@B28]). The goal of that study was to increase sleep duration by 1 h, every night, for 6 weeks. Actigraphy was used to verify that participants were short sleepers, sleeping \<7 h/night. Participants were given instructions on proper sleep hygiene and individualized sleep schedules at the beginning of the study, but no other lifestyle intervention was included. Compliance was verified every 2 weeks during the intervention. Participants successfully extended their TIB and sleep duration throughout the intervention compared to their habitual sleep, reaching an increase of 54 ± 33 min in the first 2 weeks, 48 ± 31 min over the second 2 weeks, and 44 ± 34 min over the last 2 week. At the end of the 6-week intervention, there was a significant improvement in the insulin-to-glucose ratio, indicating lessened insulin resistance. As with other studies of this type, there was no comparison group, and there was high inter-individual variation in the amount of additional sleep that was obtained.

Conclusion {#s6}
==========

There are limited clinical trials investigating the effects of sleep extension on health. The studies that have been conducted vary greatly in study length, participant characteristics, and intervention types. Two of the studies discussed did not use an objective measure of sleep to examine sleep quality and duration, providing only subjective data ([@B23], [@B27]). Additionally, while each study provided some type of sleep education, the two studies that did not objectively measure sleep were the only ones to provide continuous counseling sessions throughout the intervention period ([@B23], [@B27]). The other trials only included one counseling session at the start of the intervention, with the session content varying from study to study. The studies that used actigraphy to monitor sleep provided participants with specific sleep schedules, prescribing an extension in TIB of 1--1.5 h/night, ([@B25], [@B26], [@B28]) with the exception of one study that imposed a TIB of 8.5 h/night ([@B24]). It is worth noting that the trials that utilized objective measurements and individualized sleep extension interventions achieved greater benefits compared to the ones that utilized counseling sessions alone. Also, each study had different inclusion criteria, with two trials not requiring that participants be short sleepers at baseline ([@B23], [@B27]). Due to these study differences, it is difficult to provide recommendations regarding the impact of sleep extension on health.

Furthermore, it is unclear whether sleep quality improves as a result of sleep extension. Participants reported significant improvements of sleep quality in only one trial, ([@B27]) in which sleep was not a primary outcome and objective measures were not used. Two of the three studies that utilized objective measures of sleep reported no change in sleep quality, ([@B26], [@B28]) while the other ([@B25]) found that the sleep extension group experienced decreased sleep quality compared to the control group. However, this decline could be due to a period of adjustment that potentially would resolve over time and should be monitored in future trials. To that effect, it may be important for future studies to include a run-in period since Cizza et al. ([@B41]) have reported improvements in sleep duration of 15--30 min depending on measurement type, objective vs. subjective, respectively, during a waiting period between screening and randomization.

In addition to assessing sleep quality, future sleep extension studies would benefit from being performed exclusively in short sleepers, including larger sample sizes, measuring sleep duration and compliance using objective tools, and providing a prescribed sleep schedule in conjunction with counseling sessions throughout the intervention. In light of the decline in the average sleep duration among US adults, paired with the knowledge that short sleep increases the risk of obesity, CVD, and diabetes, it is encouraging to know that increasing sleep is a feasible endeavor that may be utilized in the future as a behavioral intervention to help alleviate these health burdens. However, standardized, longer-term, randomized intervention trials are needed to verify these preliminary findings.
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:   short sleep duration
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:   time in bed.
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